HIGHLIGHTS
- who: Jose L. Mondaza-Hernandez from the Health Research Institute Fundacion Jimenez Diaz, Universidad Autonoma de Madrid (IIS/FJD-UAM), Madrid, Spain have published the research work: ISG15 as a prognostic biomarker in solitary fibrous tumour, in the Journal: (JOURNAL)
- future: For future directions a potential clinical trial could be designed considering ISG15 effect for advanced SFT patients.
SUMMARY
The associations between the variables of interest (i.e., protein/ gene_expression and clinical outcomes) were performed by the log-rank test, statistical significance was defined at p=0.05. In the univariate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.